-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2009.jsp
January 01, 2009 - is not present, (1) Comorbidity is present
CM_RENLFAIL
2002-2009
AHRQ comorbidity measure: Renal
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2010.jsp
January 01, 2010 - is not present, (1) Comorbidity is present
CM_RENLFAIL
2002-2010
AHRQ comorbidity measure: Renal
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2011.jsp
January 01, 2011 - is not present, (1) Comorbidity is present
CM_RENLFAIL
2002-2011
AHRQ comorbidity measure: Renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
February 01, 2012 - weight)
Systemic Lupus
Erythematosus Disease
Activity Index
Lupus serology (ANA, dsDNA,
C3, C4)
Renal
-
hcup-us.ahrq.gov/db/nation/nis/NIS_2008_INTRODUCTION.pdf
January 01, 2008 - Comorbidity is not present, (1)
Comorbidity is present
CM_RENLFAIL 2002-2008 AHRQ comorbidity measure: Renal
-
hcup-us.ahrq.gov/db/nation/nis/NIS_2007_INTRODUCTION.pdf
January 01, 2007 - Comorbidity is not present, (1)
Comorbidity is present
CM_RENLFAIL 2002-2007 AHRQ comorbidity measure: Renal
-
hcup-us.ahrq.gov/db/nation/nis/reports/2003niscomparisonrpt.jsp
May 01, 2016 - (0.02)
1.29*
6.12 (0.05)
6.23*
0.00 (0.00)
0.00 1
$25,643 (711)
$25,362
316: renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
April 01, 2013 - refers to the cross-linking of
polyethylene glycol molecules to the interferon molecule, which delays renal
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cancer/fielding-cancer-53.pdf
July 14, 2017 - tumor(s)
52355* Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with resection of ureteral or renal
-
www.ahrq.gov/patient-safety/settings/long-term-care/resource/multichronic/summit-bios.html
November 01, 2021 - former Chair of the Public Policy Committee and a member of the Board of Directors of the Mid-Atlantic Renal
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - This expert added that prescribing providers would need to be willing to monitor
renal function in
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-6-tables1.pdf
January 01, 2009 - Disabled/ESRD = under 65; ESRD = end stage renal disease; AI/AN = American Indian or Alaska Native
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
October 01, 2014 - magnetic resonance imaging
changes after sorafenib and sunitinib chemotherapy in patients with advanced
renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
January 01, 2023 - non-melanoma skin cancer),
HIV infection, organ transplant, liver failure or hepatic coma, end-stage renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - This expert added that prescribing providers would need to be willing to monitor
renal function in
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-6-tables1.pdf
January 01, 2009 - Disabled/ESRD = under 65; ESRD = end stage renal disease; AI/AN = American Indian or Alaska Native
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
January 01, 2023 - non-melanoma skin cancer),
HIV infection, organ transplant, liver failure or hepatic coma, end-stage renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
October 01, 2014 - magnetic resonance imaging
changes after sorafenib and sunitinib chemotherapy in patients with advanced
renal
-
hcup-us.ahrq.gov/reports/methods/2006_9.pdf
January 01, 2006 - (5)
160** 1.34
(0.02)
1.29* 6.12
(0.05)
6.23* 0.00
(0.00)
0.001 $25,643
(711)
$25,362
316: Renal
-
hcup-us.ahrq.gov/db/nation/nis/reports/2002niscomparisonrpt.jsp
June 01, 2016 - 1.07
4.45 (0.06)
4.37
0.93 (0.07)
0.95
$22,015 (709)
$21,111
316: renal